Etymology:
bu’gi.ae. L. gen. fem. n.bugiae, of Bugie, in honour of Elizabeth Bugie for her role in the discovery of streptomycin, the first antibiotic effective against tuberculosis
Effective publication:
Nouioui I, Boldt J, Zimmermann A, Makitrynskyy R, Potter G, Jando M, Doppner M, Kirstein S, Neumann-Schaal M, Gomez-Escribano JP, et al. Biotechnological and pharmaceutical potential of twenty-eight novel type strains of Actinomycetes from different environments worldwide. Curr Res Microb Sci 2024; 7:100290. 🇩🇪
IJSEM list:
Oren A, Göker M. Validation list no. 224. List of new names and new combinations previously effectively, but not validly, published. Int J Syst Evol Microbiol 2025; 75:6801.
Nomenclatural status:
validly published under the ICNP
Taxonomic status:
correct name (and explicitly recommended for medical use)
Notes:
🎓 Name mentioned 0 times in PubMed until 2025-08-12.
🙆 This name is on the List of Recommended Names for bacteria of medical importance (LoRN) as the name to be applied to this species. The name is on LoRN because of the recorded risk group of the genus.
Assigned by:
Nouioui I, Boldt J, Zimmermann A, Makitrynskyy R, Potter G, Jando M, Doppner M, Kirstein S, Neumann-Schaal M, Gomez-Escribano JP, et al. Biotechnological and pharmaceutical potential of twenty-eight novel type strains of Actinomycetes from different environments worldwide. Curr Res Microb Sci 2024; 7:100290. 🇩🇪
Linking:
To permanently link to this page, use https://doi.org/10.83108/rn.66888Link copied to clipboard